These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

908 related items for PubMed ID: 19813250

  • 1. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
    Suzuki N, Yumura-Yagi K, Yoshida M, Hara J, Nishimura S, Kudoh T, Tawa A, Usami I, Tanizawa A, Hori H, Ito Y, Miyaji R, Oda M, Kato K, Hamamoto K, Osugi Y, Hashii Y, Nakahata T, Horibe K, Japan Association of Childhood Leukemia Study (JACLS).
    Pediatr Blood Cancer; 2010 Jan; 54(1):71-8. PubMed ID: 19813250
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
    Oudot C, Auclerc MF, Levy V, Porcher R, Piguet C, Perel Y, Gandemer V, Debre M, Vermylen C, Pautard B, Berger C, Schmitt C, Leblanc T, Cayuela JM, Socie G, Michel G, Leverger G, Baruchel A.
    J Clin Oncol; 2008 Mar 20; 26(9):1496-503. PubMed ID: 18349402
    [Abstract] [Full Text] [Related]

  • 3. [Clinical study of Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Bao L, Jiang B, Huang XJ, Wang DB, Qiu JY, Lu XJ, Chen H, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan 20; 26(1):31-4. PubMed ID: 15946506
    [Abstract] [Full Text] [Related]

  • 4. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
    Ribera JM, Ortega JJ, Oriol A, Fontanillas M, Hernández-Rivas JM, Brunet S, García-Conde J, Maldonado J, Zuazu J, Gardella S, Besalduch J, León P, Macià J, Domingo-Albós A, Feliu E, San Miguel JF.
    Haematologica; 1998 Mar 20; 83(3):222-30. PubMed ID: 9573676
    [Abstract] [Full Text] [Related]

  • 5. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A, Robak T, Pluta A, Zwolińska M, Wawrzyniak E, Wierzbowska A, Skotnicki A, Jakubas B, Hołowiecki J, Nowak K, Kuliczkowski K, Mazur G, Haus O, Dmoszyńska A, Adamczyk-Cioch M, Jedrzejczak WW, Paluszewska M, Konopka L, Pałynyczko G.
    Ann Hematol; 2006 Jun 20; 85(6):366-73. PubMed ID: 16523310
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.
    Biol Blood Marrow Transplant; 2008 Jun 20; 14(6):685-92. PubMed ID: 18489994
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
    Hunault M, Truchan-Graczyk M, Caillot D, Harousseau JL, Bologna S, Himberlin C, Guyotat D, Berthou C, Casassus P, Baranger L, Béné MC, Ifrah N, Gyan E, GOELAMS Group.
    Haematologica; 2007 Dec 20; 92(12):1623-30. PubMed ID: 18055985
    [Abstract] [Full Text] [Related]

  • 14. [Clinical characteristics and outcomes of 59 patients with acute lymphoblastic leukemia positive for BCR/ABL].
    Liu Z, Liu XL, Du QF, Xu N, Zhong M, Song LL, Yi ZS, Liu QF, Meng FY, Zhou SY.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar 20; 29(3):512-5. PubMed ID: 19304540
    [Abstract] [Full Text] [Related]

  • 15. Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.
    Thomas X, Thiebaut A, Olteanu N, Danaïla C, Charrin C, Archimbaud E, Fiere D.
    Hematol Cell Ther; 1998 Jun 20; 40(3):119-28. PubMed ID: 9698220
    [Abstract] [Full Text] [Related]

  • 16. [Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].
    Mi YC, Xue YP, Yu WJ, Liu SH, Zhao YZ, Meng QX, Bian SG, Wang JX.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec 20; 26(12):705-9. PubMed ID: 16620570
    [Abstract] [Full Text] [Related]

  • 17. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, Lakomek M, Henze G, von Stackelberg A.
    J Clin Oncol; 2009 Jul 10; 27(20):3363-9. PubMed ID: 19433688
    [Abstract] [Full Text] [Related]

  • 18. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group.
    Eur J Haematol; 2007 Feb 10; 78(2):102-10. PubMed ID: 17087744
    [Abstract] [Full Text] [Related]

  • 19. [Peripheral blood stem cell autografts (PBSCT) in the treatment of 30 children with acute leukemias and lymphoma].
    Abe T, Takaue Y, Matsunaga K, Saito S, Hirao A, Okamoto Y, Nakanishi J, Watanabe T, Kawano Y, Ninomiya T.
    Rinsho Ketsueki; 1991 Nov 10; 32(11):1425-32. PubMed ID: 1758049
    [Abstract] [Full Text] [Related]

  • 20. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC).
    Houtenbos I, Bracho F, Davenport V, Slack R, van de Ven C, Suen Y, Killen R, Shen V, Cairo MS.
    Bone Marrow Transplant; 2001 Jan 10; 27(2):145-53. PubMed ID: 11281383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.